Avivo Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
8
Avivo General Information
Description
Developer of a health-tech platform intended to make blood groups irrelevant for transfusion or organ transplant. The company's platform uses a proprietary technology that is a combination of two enzymes that first prime and then eliminate a marker on the red blood cell that determines blood group A, enabling hospitals to use any blood type for any patient safely.
Contact Information
Website
www.avivobio.comCorporate Office
- 595 Burrard Street
- Suite 2600, Post Office Box 49314
- Vancouver, British Columbia V7X 1L3
- Canada
Corporate Office
- 595 Burrard Street
- Suite 2600, Post Office Box 49314
- Vancouver, British Columbia V7X 1L3
- Canada
Avivo Timeline
Avivo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 01-Jan-2026 | Completed | Pre-Clinical Trials | |||
| 7. Accelerator/Incubator | 10-Dec-2025 | Completed | Pre-Clinical Trials | |||
| 6. Grant | 31-Mar-2022 | Completed | Pre-Clinical Trials | |||
| 5. Seed Round | 31-Mar-2022 | Completed | Pre-Clinical Trials | |||
| 4. Grant | Completed | Pre-Clinical Trials | ||||
| 3. Seed Round | 28-Feb-2021 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Avivo Signals
Avivo Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Scale Up Canada | Accelerator/Incubator | |||
| Diana (UK) | Accelerator/Incubator | |||
| Genome British Columbia | Not-For-Profit Venture Capital | |||
| Little Green Bamboo Capital | Venture Capital | Minority | ||
| WUTIF Capital | Angel Group | Minority |
Avivo FAQs
-
When was Avivo founded?
Avivo was founded in 2020.
-
Where is Avivo headquartered?
Avivo is headquartered in Vancouver, Canada.
-
What is the size of Avivo?
Avivo has 14 total employees.
-
What industry is Avivo in?
Avivo’s primary industry is Biotechnology.
-
Is Avivo a private or public company?
Avivo is a Private company.
-
What is Avivo’s current revenue?
The current revenue for Avivo is .
-
How much funding has Avivo raised over time?
Avivo has raised $3.23M.
-
Who are Avivo’s investors?
Scale Up Canada, Diana (UK), Genome British Columbia, Little Green Bamboo Capital, and WUTIF Capital are 5 of 8 investors who have invested in Avivo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process